Obesity drug WEGOVY® under the microscope: who loses the most weight?
NCT ID NCT05897398
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study followed 1,100 adults with severe obesity who were taking the weight-loss drug WEGOVY®. Researchers tracked weight changes over 12 months and looked for patterns in who lost the most weight. They also used artificial intelligence to find clues—like certain health markers—that might predict a person's success with the treatment. The goal is to help doctors personalize obesity care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Espace Médical Nutrition & Obésité (EMNO) Maison Médicale Valmy
Dijon, 21000, France
-
Service Endocrinologie Diabète Nutrition Hôpitaux de Brabois - CHU Nancy
Vandœuvre-lès-Nancy, 54500, France
-
Service Endocrinologie Diabétologie CHU de Grenoble
La Tronche, 38250, France
-
Service Endocrinologie Diabétologie Maladies Métaboliques CHU François Mitterrand Dijon
Dijon, 21079, France
-
Service Endocrinologie Diabétologie Nutrition APHP - Hôpital Jean Verdier
Bondy, 93140, France
-
Service Endocrinologie Diabétologie Nutrition CHU Poitiers
Poitiers, 86021, France
-
Service Endocrinologie Diabétologie Nutrition CHU de Nantes - Hôpital Guillaume & René Laennec
Nantes, 44093, France
-
Service Endocrinologie Diabétologie Nutrition Hôpital Lapeyronie - CHU Montpellier
Montpellier, 34295, France
-
Service Endocrinologie Hôpital Conception - APHM
Marseille, 13385, France
-
Service Endocrinologie Hôpital Haut Léveque - CHU Bordeaux
Pessac, 33604, France
-
Service Endocrinologie, Maladies Métaboliques et Nutrition Hôpital Rangueil (CHU Toulouse)
Toulouse, 31059, France
-
Service Nutrition APHP - GHU Pitié Salpêtrière
Paris, 75013, France
-
Service Nutrition Diabétologie Endocrinologie APHP - Hôpital Européen Georges-Pompidou (HEGP)
Paris, 75015, France
-
Service de chirurgie APHP - GHU Nord Hôpital Louis Mourier
Colombes, 92700, France
Conditions
Explore the condition pages connected to this study.